Baillie Gifford & Co’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-121,855
Closed -$992K 276
2024
Q3
$992K Sell
121,855
-308,742
-72% -$2.23M ﹤0.01% 254
2024
Q2
$2.75M Sell
430,597
-106,171
-20% -$682K ﹤0.01% 239
2024
Q1
$4.04M Sell
536,768
-1,550
-0.3% -$14.1K ﹤0.01% 242
2023
Q4
$4.98M Sell
538,318
-28,818
-5% -$235K ﹤0.01% 239
2023
Q3
$5.74M Sell
567,136
-23,318
-4% -$278K 0.01% 231
2023
Q2
$7.38M Sell
590,454
-11,309
-2% -$135K 0.01% 229
2023
Q1
$7.02M Buy
601,763
+2,851
+0.5% +$36.3K 0.01% 234
2022
Q4
$6.37M Buy
598,912
+192,959
+48% +$1.86M 0.01% 238
2022
Q3
$3.94M Buy
405,953
+13,436
+3% +$178K ﹤0.01% 247
2022
Q2
$5.69M Sell
392,517
-47,650
-11% -$812K 0.01% 228
2022
Q1
$11.5M Buy
440,167
+41,788
+10% +$1.19M 0.01% 230
2021
Q4
$15.8M Buy
398,379
+17,376
+5% +$792K 0.01% 230
2021
Q3
$19.1M Buy
381,003
+81,441
+27% +$4.44M 0.01% 227
2021
Q2
$16.6M Buy
299,562
+36,732
+14% +$1.96M 0.01% 234
2021
Q1
$12.3M Buy
262,830
+140,777
+115% +$6.82M 0.01% 237
2020
Q4
$5.31M Buy
122,053
+59,738
+96% +$2.2M ﹤0.01% 231
2020
Q3
$2.28M Buy
62,315
+56,328
+941% +$1.91M ﹤0.01% 229
2020
Q2
$175K Buy
5,987
+2,635
+79% +$72.8K ﹤0.01% 238
2020
Q1
$88K Buy
3,352
+860
+35% +$26.3K ﹤0.01% 219
2019
Q4
$86K Hold
2,492
﹤0.01% 220
2019
Q3
$79K Buy
+2,492
New +$98.1K ﹤0.01% 220

Other funds holding HCAT